The fool with email

Day after day, alone with email The man with the foolish thoughts
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Day after day, alone with email
The man with the foolish thoughts
Writes an editorial.
But nobody takes him serious,
They can see that he likes to fool,
And he provides some respite
 
But the fool with email
Sees the year winding down,
And the thoughts in his head,
Make a jing-jangly sound.
 
Well on their way, in 2006,
Pharma with a thousand choices,
Many leads do abound.
But nobody knows which one will
Improve the old bottom line.
They hope in the new fiscal season
 
That their pipelines will swell
As the techniques improve,
And the patients get well
With the drugs Feds approve.
 
While none can predict the future,
They know how they would like to do,
Even still they show their feelings
That the folks in great need
On the globe that we live
Make a new crop of meds
A great imperative.
 
With our help these folks'll go on,
'cuz they know that we've the tools
To help the world.
And this fool with email
Wishes you and yours well,
As another year dawns
And we see hope yet swell.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Image Alt Text	A laboratorian wearing blue gloves places a PCR sample into a real-time PCR thermocycler, the model shown is blue and white with a large digital screen.
From primer design to sample preparation, explore comprehensive strategies to optimize PCR throughput and reproducibility.
Tackling mycoplasma contamination in biotherapeutic production
DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.
Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue